製品別ポイントオブケア診断市場（血糖モニタリングキット、感染症検査キット、妊娠・妊孕性検査キット、血液学検査キット、心臓代謝モニタリングキット、尿検査キット、コレステロール検査ストリップ、薬物乱用検査キット、その他）、モード別処方箋（処方箋ベースのデバイス、OTCベースのデバイス）、エンドユーザー別（専門的診断センター、研究所、在宅医療、その他）：世界的な機会分析と業界予測、2020年から2030年

The utilization of point-of-care diagnostic devices is expected to witness a significant rise with the increase in diagnostic procedures for diseases and innovative and advanced applications of devices. The point-of-care diagnostic market is the point of interest of healthcare providers due to several benefits offered by these devices to investigate and manage various medical conditions. Remarkable technological advancements in the POC diagnostic devices to provide advanced diagnosis options for the investigation of diseases, such as diabetes, cardiac diseases, cancer, and others are also observed. As the market is saturated and grows at a steady rate in developed nations, Asia-Pacific and LAMEA regions are expected to offer high growth opportunities to key players in the market.

An increase in the prevalence of various infectious diseases, technological advancements, and a rise in emphasis on early prevention are some of the major factors that drive the market. However, a lack of reimbursement and stringent regulations for the approval of POC diagnostic devices hamper the growth of the market. Currently, glucose monitoring kits are the largest segment in the global point-of-care diagnostics market, followed by hematology testing kits. The rise in incidences coupled with growth in the geriatric population and initiatives are taken by various government associations for free blood check-ups add to the growth of the point-of-care diagnostic market. The infectious disease testing kits segment is the most attractive segment of the point-of-care diagnostics market, owing to the increase in the need for these devices at hospitals and other healthcare facilities.

The professional diagnostic centers are the major end-user in the point-of-care diagnostic devices. This is due to the increase in the number of healthcare facilities that include hospitals and clinics globally. Furthermore, the POC diagnostic devices are usually prescribed by healthcare professionals due to extensive knowledge about the various medical conditions among healthcare professionals and their management. Thus, the prescription-based POC diagnostic devices segment holds the largest market share in the market.

In addition, emerging markets gain more importance for the majority of the POC diagnostic device manufacturers and distributors. Rapid growth was observed in the shipments of these devices to provide improved healthcare services in emerging nations, and this is expected to offset the challenging conditions in mature markets such as North America and Europe. North America is expected to dominate the global point-of-care diagnostics market during the forecast period, followed by Europe.